In 2018 Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, and the University of Washington went live with an enterprise Clinical Trial Management System (CTMS).
This CTMS serves as a single, centralized, web-based enterprise resource to support clinical research studies conducted within or across the three institutions.
This National Cancer Institute (NCI) mandated system serves to:
The CTMS Program Office is responsible for the implementation and ongoing operation of the CTMS and maintains neutrality across the three institutions. The CTMS Program Office aims to empower study teams to advance clinical research and enable administrators to gain insight on research data through collaboration across our institutions.
Need access? Contact Us.
As part of our continued roll-out of OnCore functionality, the storage and access of protocol documents will be moving from FYI to OnCore CTMS (anticipated go-live June 21, 2021). This move will enable study teams to directly manage documents available for access and download. All existing FYI......
In 2017 the University of Washington (UW), Fred Hutchinson Cancer Research Center, and Seattle Cancer Care Alliance (SCCA) formed the CTMS Program Office to support the implementation of an enterprise Clinical Trial Management System (CTMS). After the July 2018 go-live of OnCore CTMS, the Program......
The CTMS Executive Sponsor Committee has approved an updated Target 3 (T3) roll-out date of September 13, 2021 to accommodate the updated D1 go-live date in March. The T3 implementation project focuses on rolling out study calendars and financials functionality in OnCore CTMS for Oncology......
Zendesk Guide is a communications management tool that provides a dedicated space for study teams to track communications with central research offices, including CTMS Program Office, UW Clinical Trials Office (CTO) and UW Clinical Research Budget & Billing (CRBB). Central research offices have been using......
The CTMS Target 3 (T3) Pilot officially launched on Monday, October 5, 2020. Two oncology and one UW-non-oncology pilot study teams were selected to run through Target 3 workflows for all new studies submitted through REDCap on or after October 5th. We are grateful to......
On June 1, 2020, the SCCA, Fred Hutch and UW Medicine are jointly implementing a new REDCap study activation process to improve research startup. All Consortium and Fred Hutch non-oncology human subjects research (i.e., any study that would currently be entered into OnCore and/or SRAMP) will......
